Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-05-09 00:00:00 ET · period of report 2025-05-07 · accession 0001415889-25-012571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-05-09 | 2025-05-07+ | KNSA | Patel Sanj K | COB, CEO, Dir | S - Sale+OE | $27.04 | -8,095 | 96.7K | -8% | -$218.9K |
| DM | 2025-05-09 | 2025-05-07+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $1.59 | +8,095 | 96.8K | +9% | +$12.9K |
| DM | 2025-05-09 | 2025-05-07+ | KNSA | Patel Sanj K | COB, CEO, Dir | M - OptEx | $0.00 | -8,095 | 97.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-05-07 | S | D | 1,965 | $27.00 | 96,674 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.03 and $27.14. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 2 | Common | Class A Ordinary Share | 2025-05-09 | M | A | 6,029 | $1.59 | 102,703 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-05-07 | M | A | 1,965 | $1.59 | 98,639 | D | — | — | |
| 4 | Common | Class A Ordinary Share | 2025-05-09 | S | D | 6,029 | $27.05 | 96,674 | D | — | — | (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $27.03 and $27.14. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price. |
| 5 | Common | Class A Ordinary Share | 2025-05-08 | M | A | 101 | $1.59 | 96,775 | D | — | — | |
| 6 | Common | Class A Ordinary Share | 2025-05-08 | S | D | 101 | $27.00 | 96,674 | D | — | — | |
| 7 | Derivative | Share Option | 2025-05-09 | M | D | 6,029 | $0.00 | 91,491 | D | $1.59 · — to 2025-12-15 | 6,029 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |
| 8 | Derivative | Share Option | 2025-05-07 | M | D | 1,965 | $0.00 | 97,621 | D | $1.59 · — to 2025-12-15 | 1,965 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |
| 9 | Derivative | Share Option | 2025-05-08 | M | D | 101 | $0.00 | 97,520 | D | $1.59 · — to 2025-12-15 | 101 Class A Ordinary Share | (F3) The option is fully vested and exercisable. |